Intravenous Ketamine Infusions in Treatment-Resistant Bipolar Depression: An Open-Label Naturalistic Observational Study.

Alina Wilkowska Adam Wlodarczyk Maria Gałuszko-WęgielnikMariusz S WigluszWiesław Jerzy Cubała

Published in: Neuropsychiatric disease and treatment (2021)

This report presents the preliminary results of IV ketamine effectiveness and safety in treatment-resistant bipolar depression. The findings suggest that it is a feasible, safe and well-tolerated treatment option in this group of patients. There is a definite need for more studies in this field.

Keyphrases

end stage renal disease
depressive symptoms
bipolar disorder
newly diagnosed
chronic kidney disease
pain management
sleep quality
prognostic factors
patient reported outcomes
physical activity
patient reported